UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever

Clinical infectious diseases, 2010-12, Vol.51 (12), p.1435-1441

2010

Volltextzugriff (PDF)

The effect of chronic renal failure on drug metabolism and transport

Expert opinion on drug metabolism & toxicology, 2008-08, Vol.4 (8), p.1065-1074

2008

Volltextzugriff (PDF)

Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1- Monoinfected Participants: A Phase II Clinical Trial

The Journal of infectious diseases, 2010-06, Vol.201 (11), p.1686-1696

2010

Volltextzugriff (PDF)

Safety and pharmacokinetics of naringenin: A randomized, controlled, single‐ascending‐dose clinical trial

Diabetes, obesity & metabolism, 2020-01, Vol.22 (1), p.91-98

2020

Volltextzugriff (PDF)

Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093

Contraception (Stoneham), 2008-02, Vol.77 (2), p.84-90

2008

Volltextzugriff (PDF)

Principles of Clinical Pharmacology

3rd ed., 2012

Volltextzugriff (PDF)

In Memoriam Arthur J. Atkinson, Jr. (1938–2024)

Clinical pharmacology and therapeutics, 2024-05, Vol.116 (1), p.20-21

2024

Volltextzugriff (PDF)

Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases

Regulatory peptides, 2008-01, Vol.145 (1), p.24-32

2008

Volltextzugriff (PDF)

Depo-medroxyprogesterone in Women on Antiretroviral Therapy: Effective Contraception and Lack of Clinically Significant Interactions

Clinical pharmacology and therapeutics, 2007-02, Vol.81 (2), p.222-227

2007

Volltextzugriff (PDF)

Cytochrome P4502C9 activity in end-stage renal disease

Clinical pharmacology and therapeutics, 2003-05, Vol.73 (5), p.475-477

2003

Volltextzugriff (PDF)

The Effect of Chronic Renal Failure on Hepatic Drug Metabolism and Drug Disposition

Seminars in dialysis, 2003-01, Vol.16 (1), p.45-50

2003

Volltextzugriff (PDF)

Plasma elimination of cardiac troponin I in end-stage renal disease

Southern medical journal (Birmingham), 2001-10, Vol.94 (10), p.993-996

2001

Volltextzugriff (PDF)

Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers

PLoS clinical trials, 2007-01, Vol.2 (1), p.e6

2007

Volltextzugriff (PDF)

Integrating pharmacogenetic information and clinical decision support into the electronic health record

Journal of the American Medical Informatics Association : JAMIA, 2014-05, Vol.21 (3), p.522-528

2014

Volltextzugriff (PDF)

Salt Loading Increases Urinary Excretion of Linoleic Acid Diols and Triols in Healthy Human Subjects

Hypertension (Dallas, Tex. 1979), 2008-03, Vol.51 (3), p.755-761

2008

Volltextzugriff (PDF)

Clinical Pharmacology Education and Training at the National Institutes of Health

Clinical pharmacology and therapeutics, 2007-06, Vol.81 (6), p.907-909

2007

Volltextzugriff (PDF)

Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: A case study

Peptides (New York, N.Y. : 1980), 2007-09, Vol.28 (9), p.1891-1895

2007

Volltextzugriff (PDF)

The Prevalence of CYP2C8, 2C9, 2J2, and Soluble Epoxide Hydrolase Polymorphisms in African Americans With Hypertension

American journal of hypertension, 2005-10, Vol.18 (10), p.1276-1281

2005

Volltextzugriff (PDF)

Emergence of biomarkers in nephropharmacology

Biomarkers in medicine, 2010-12, Vol.4 (6), p.805-814

2010

Volltextzugriff (PDF)

Atkinson's Principles of Clinical Pharmacology

Fourth edition, 2021

Volltextzugriff (PDF)

Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis

Clinical pharmacology and therapeutics, 2018-03, Vol.103 (3), p.390-394

2018

Volltextzugriff (PDF)

Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus

Clinical pharmacology and therapeutics, 1994-09, Vol.56 (3), p.272-278

1994

Volltextzugriff (PDF)

Palliative uses of methylphenidate in patients with cancer: A review

Journal of clinical oncology, 2002, Vol.20 (1), p.335-339

2002

Volltextzugriff (PDF)

Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity

Clinical pharmacology and therapeutics, 1995-11, Vol.58 (5), p.498-505

1995

Volltextzugriff (PDF)

A Message From The Scientific Program Committee Chairperson: Submission Of Abstracts For The 1996 Annual Meeting

Clinical pharmacology and therapeutics, 1995-06, Vol.57 (6), p.701-701

Lertora, Juan J. L

1995

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(46)
Humans
(41)
Biological And Medical Sciences
(29)
Medical Sciences
(27)
Male
(26)
Adult
(20)
Middle Aged
(18)
Pharmacology & Pharmacy
(17)
Pharmacology. Drug Treatments
(17)
Animals
(16)
Pharmacology
(16)
Female
(12)
Infectious Diseases
(9)
Hiv Infections - Drug Therapy
(8)
Pharmacokinetics
(8)
Procainamide - Analogs & Derivatives
(8)
Time Factors
(8)
Aids/hiv
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever

The effect of chronic renal failure on drug metabolism and transport

Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1- Monoinfected Participants: A Phase II Clinical Trial

Safety and pharmacokinetics of naringenin: A randomized, controlled, single‐ascending‐dose clinical trial

Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093

Principles of Clinical Pharmacology

In Memoriam Arthur J. Atkinson, Jr. (1938–2024)

Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases

Depo-medroxyprogesterone in Women on Antiretroviral Therapy: Effective Contraception and Lack of Clinically Significant Interactions

Cytochrome P4502C9 activity in end-stage renal disease

The Effect of Chronic Renal Failure on Hepatic Drug Metabolism and Drug Disposition

Plasma elimination of cardiac troponin I in end-stage renal disease

Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers

Integrating pharmacogenetic information and clinical decision support into the electronic health record

Salt Loading Increases Urinary Excretion of Linoleic Acid Diols and Triols in Healthy Human Subjects

Clinical Pharmacology Education and Training at the National Institutes of Health

Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: A case study

The Prevalence of CYP2C8, 2C9, 2J2, and Soluble Epoxide Hydrolase Polymorphisms in African Americans With Hypertension

Emergence of biomarkers in nephropharmacology

Atkinson's Principles of Clinical Pharmacology

Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis

Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus

Palliative uses of methylphenidate in patients with cancer: A review

Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity

A Message From The Scientific Program Committee Chairperson: Submission Of Abstracts For The 1996 Annual Meeting

Suchergebnisse filtern